Cargando…

Relationship of Change in Plasma Clozapine/N-desmethylclozapine Ratio with Cognitive Performance in Patients with Schizophrenia

OBJECTIVE: The clozapine/N-desmethylclozapine (NDMC) ratio is proposed to be used as a predictor of cognitive performance in clozapine-treated patients, as its principal metabolite, NDMC, has an opposite action with clozapine on the cholinergic system. The aim of this study is to determine whether c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Royun, Kim, Seoyoung, Kim, Euitae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711124/ https://www.ncbi.nlm.nih.gov/pubmed/33198433 http://dx.doi.org/10.30773/pi.2020.0306

Ejemplares similares

Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
por: Costa-Dookhan, Kenya A., et al.
Publicado: (2021)

Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia
por: Vaquero-Baez, Mayela, et al.
Publicado: (2019)

The Value of Desmethylclozapine and Serum CRP in Clozapine Toxicity: A Case Report
por: Abou Farha, Khalid, et al.
Publicado: (2012)

Associations of Clozapine Use With Psychosocial Functioning and Quality of Life in Patients With Schizophrenia: A Community-Based Cross-Sectional Study
por: Kim, Sujin, et al.
Publicado: (2021)

The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [(11)C]-raclopride PET study with aripiprazole
por: Shin, Sangho, et al.
Publicado: (2018)

N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle
por: Medigeshi, Guruprasad R., et al.
Publicado: (2016)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
por: Kammoun, I., et al.
Publicado: (2022)

S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
por: Kim, Seoyoung, et al.
Publicado: (2018)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

M60. EARLY VERSUS DELAYED PRESCRIPTION OF CLOZAPINE AND THE COGNITIVE PERFORMANCE ON SCHIZOPHRENIA
por: Amoretti, Silvia, et al.
Publicado: (2020)

S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
por: Kim, Seoyoung, et al.
Publicado: (2020)

Relationship between subjective well-being and aripiprazole: an [(11)C]raclopride PET study
por: Kim, Seoyoung, et al.
Publicado: (2022)

T137. THE RELATIONSHIP BETWEEN CORTICOSTRIATAL CONNECTIVITY AND STRIATAL DOPAMINE FUNCTION IN SCHIZOPHRENIA: AN 18F-DOPA PET AND DIFFUSION TENSOR IMAGING STUDY
por: Shin, Sangho, et al.
Publicado: (2020)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia
por: Kikuchi, Yuka Sugawara, et al.
Publicado: (2019)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

S214. HEART RATE VARIABILITY PREDICTS CLOZAPINE PLASMA LEVEL IN PATIENTS WITH SCHIZOPHRENIA IN A POLYPHARMACY CONDITION
por: Mi Park, Su, et al.
Publicado: (2020)

Long-term treatment with clozapine and verbal memory performance in schizophrenia
por: Czepielewski, Letícia S., et al.
Publicado: (2018)

Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2017)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)

Long-Term Changes in Self-Report Auditory Verbal Hallucinations in Patients with Schizophrenia Using Clozapine
por: Chung, In Won, et al.
Publicado: (2019)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
por: Johannsen, Claas-Frederik, et al.
Publicado: (2022)

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
por: Hribkova, Hana, et al.
Publicado: (2022)

Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia
por: Lee, Joomi, et al.
Publicado: (2021)

PM493. Interactions of tardive dyskinesia with cognitive function in patients with schizophrenia: worsening of working memory with clozapine treatment
por: Kim, Soo In, et al.
Publicado: (2016)

A False Case of Clozapine-Resistant Schizophrenia
por: Maia-de-Oliveira, J. P., et al.
Publicado: (2010)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013)

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
por: Goldstein, Meghan Elizabeth, et al.
Publicado: (2015)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s19nfsofnsogovalalhfplc2b5